Christopher van Dyck, MD
Yale University
- 3 editions
- 4 talks
- 2 recordings
2026
- Symposium Long-term Treatment with Anti-Amyloid Therapy: Applying Trial Data to Real-world Decisions about Effectiveness
2025
- Symposium Effect of Long-Term Maintenance Anti-amyloid Treatment
2023
- Symposium · Keynote The Clarity AD Trial with Lecanemab and the Potential of Plasma Biomarkers for Tracking Treatment Response
- Public Forum The Clarity Trial with Lecanemab for Alzheimer’s Disease
Degrees and affiliation are current where known; the program pages show affiliations as they were each year.